Previously, some studies focused on the susceptibility of the Cyclin D1 (CCND1) G870A gene polymorphism to several type of cancer, including bladder cancer, breast cancer, colorectal cancer, leukemia and lung cancer [10–13]. This evidence concerns the gene CCND1 and urinary bladder cancer.